LINC01711 is markedly expressed in esophageal cancer and has been linked to substandard prognosis by promoting tumor cells proliferation, migration, and invasion properties through FSCN1 upregulation and miR-326 downregulation39. Here, LINC01711 is linked to esophageal cancer.